Marvin 05290916072D 9 8 0 0 1 0 999 V2000 13.3737 -9.7067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6569 -9.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.0867 -9.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3699 -10.5291 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.9400 -9.7067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6532 -8.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.7960 -9.7067 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 14.0829 -8.4655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.2308 -9.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 2 0 0 0 0 2 5 1 0 0 0 0 2 6 1 0 0 0 0 3 7 1 0 0 0 0 3 8 2 0 0 0 0 5 9 1 0 0 0 0 M END > CHEBI:35932 > 3-methyl-2-oxovaleric acid > A 2-oxo monocarboxylic acid that is valeric acid carrying oxo- and methyl substituents at C-2 and C-3, respectively. An α-keto acid analogue and metabolite of isoleucine in man, animals and bacteria. Used as a clinical marker for maple syrup urine disease (MSUD). > 3 > ketoisoleucine; alpha-oxo-beta-methylvaleric acid; alpha-Oxo-beta-methylvaleric acid; alpha-oxo-beta-methyl-n-valeric acid; alpha-keto-beta-methylvaleric acid; alpha-keto-beta-methyl-n-valeric acid; 3-methyl-2-oxovaleric acid; 3-Methyl-2-oxopentanoic acid; 3-methyl-2-oxopentanoic acid; 3-ethyl-3-methylpyruvic acid; 2-oxokolavenic acid; 2-Oxoisoleucine; 2-Oxo-3-methylvaleric acid; 2-Oxo-3-methylvalerate; 2-Oxo-3-methylpentanoic acid; 2-Oxo-3-methyl-n-valeric acid > 3-methyl-2-oxopentanoic acid > C6H10O3 > 130.14180 > 130.06299 > 0 > CCC(C)C(=O)C(O)=O > InChI=1S/C6H10O3/c1-3-4(2)5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9) > JVQYSWDUAOAHFM-UHFFFAOYSA-N > 1460-34-0 > 971983 > 1098987 > 1460-34-0 > C03465 > 1638756; 17190852; 759179 $$$$